{
"info": {
"nct_id": "NCT02726009",
"official_title": "An Open-label, Single-Arm, Multicenter, Phase IV Trial to Evaluate the Safety of Firmagon® in Androgen Deprivation Therapy in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer",
"inclusion_criteria": "* Has given written informed consent before any study-related activity is performed\n* Advanced hormone-dependent prostate cancer for which androgen deprivation therapy is indicated, and independently from this trial, Firmagon® is intended to be used for treatment\n* Age greater than or equal to 18 years and less than 80 years\n* Advanced hormone-dependent prostate cancer without any other clinically significant disorder\n* Easten Cooperative Oncology Group score ≤ 2\n* PSA ≥ 2 ng/mL at screening\n* Life expectancy of at least 12 months as per the investigator's judgement\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 79 Years",
"exclusion_criteria": "* Previous or concurrent hormonal management of prostate cancer\n* Contraindication for prescription of Firmagon®\n* Concurrent treatment with a 5-α-reductase inhibitor\n* Considered as a candidate for curative therapy\n* History of severe untreated asthma, anaphylactic reactions or severe urticaria and/or angioedema\n* QTc interval over 450 msec or risk factors for torsades de pointes or on Class IA and Class III anti arrhythmic medications\n* Cancer within the last 5 years except prostate cancer and surgically removed basal or squamous cell carcinoma of the skin\n* Known or suspected hepatic, symptomatic biliary disease (this includes moderate to severe chronic hepatic impairment)\n* Patients with clinically significant laboratory abnormalities / disorders other than prostate cancer\n* Patient with Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Has given written informed consent before any study-related activity is performed",
"criterions": [
{
"exact_snippets": [
"Has given written informed consent"
],
"criterion": "informed consent",
"requirement_type": "given",
"expected_value": true
}
]
},
{
"line": "* Advanced hormone-dependent prostate cancer for which androgen deprivation therapy is indicated, and independently from this trial, Firmagon® is intended to be used for treatment",
"criterions": [
{
"exact_snippets": [
"Advanced hormone-dependent prostate cancer"
],
"criterion": "prostate cancer",
"requirement_type": "type",
"expected_value": "advanced hormone-dependent"
},
{
"exact_snippets": [
"androgen deprivation therapy is indicated"
],
"criterion": "androgen deprivation therapy",
"requirement_type": "indication",
"expected_value": true
},
{
"exact_snippets": [
"Firmagon® is intended to be used for treatment"
],
"criterion": "Firmagon®",
"requirement_type": "intended use",
"expected_value": "treatment"
}
]
},
{
"line": "* Age greater than or equal to 18 years and less than 80 years",
"criterions": [
{
"exact_snippets": [
"Age greater than or equal to 18 years",
"less than 80 years"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18
},
{
"operator": "<",
"value": 80
}
]
}
}
]
},
{
"line": "* Advanced hormone-dependent prostate cancer without any other clinically significant disorder",
"criterions": [
{
"exact_snippets": [
"Advanced hormone-dependent prostate cancer"
],
"criterion": "prostate cancer",
"requirement_type": "type",
"expected_value": "advanced hormone-dependent"
},
{
"exact_snippets": [
"without any other clinically significant disorder"
],
"criterion": "other clinically significant disorder",
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"line": "* Easten Cooperative Oncology Group score ≤ 2",
"criterions": [
{
"exact_snippets": [
"Easten Cooperative Oncology Group score ≤ 2"
],
"criterion": "Easten Cooperative Oncology Group score",
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2
}
]
}
}
]
},
{
"line": "* PSA ≥ 2 ng/mL at screening",
"criterions": [
{
"exact_snippets": [
"PSA ≥ 2 ng/mL"
],
"criterion": "PSA",
"requirement_type": "level",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2
}
]
}
}
]
},
{
"line": "* Life expectancy of at least 12 months as per the investigator's judgement",
"criterions": [
{
"exact_snippets": [
"Life expectancy of at least 12 months"
],
"criterion": "life expectancy",
"requirement_type": "minimum duration",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 12
}
]
}
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "healthy volunteers",
"requirement_type": "participation",
"expected_value": true
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": [
"Must be MALE"
],
"criterion": "gender",
"requirement_type": "specific value",
"expected_value": "male"
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
},
{
"line": "Must have maximum age of 79 Years",
"criterions": [
{
"exact_snippets": [
"maximum age of 79 Years"
],
"criterion": "age",
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 79
}
}
]
}
],
"exclusion_lines": [
{
"line": "* Previous or concurrent hormonal management of prostate cancer",
"criterions": [
{
"exact_snippets": [
"Previous or concurrent hormonal management of prostate cancer"
],
"criterion": "hormonal management of prostate cancer",
"requirement_type": "temporal",
"expected_value": [
"previous",
"concurrent"
]
}
]
},
{
"line": "* Contraindication for prescription of Firmagon®",
"criterions": [
{
"exact_snippets": [
"Contraindication for prescription of Firmagon®"
],
"criterion": "Firmagon® prescription",
"requirement_type": "contraindication",
"expected_value": true
}
]
},
{
"line": "* Concurrent treatment with a 5-α-reductase inhibitor",
"criterions": [
{
"exact_snippets": [
"Concurrent treatment",
"5-α-reductase inhibitor"
],
"criterion": "5-α-reductase inhibitor",
"requirement_type": "concurrent treatment",
"expected_value": true
}
]
},
{
"line": "* Considered as a candidate for curative therapy",
"criterions": [
{
"exact_snippets": [
"Considered as a candidate for curative therapy"
],
"criterion": "curative therapy",
"requirement_type": "eligibility",
"expected_value": true
}
]
},
{
"line": "* History of severe untreated asthma, anaphylactic reactions or severe urticaria and/or angioedema",
"criterions": [
{
"exact_snippets": [
"History of severe untreated asthma"
],
"criterion": "asthma",
"requirement_type": "severity",
"expected_value": "severe"
},
{
"exact_snippets": [
"History of severe untreated asthma"
],
"criterion": "asthma",
"requirement_type": "treatment status",
"expected_value": false
},
{
"exact_snippets": [
"anaphylactic reactions"
],
"criterion": "anaphylactic reactions",
"requirement_type": "history",
"expected_value": true
},
{
"exact_snippets": [
"severe urticaria"
],
"criterion": "urticaria",
"requirement_type": "severity",
"expected_value": "severe"
},
{
"exact_snippets": [
"angioedema"
],
"criterion": "angioedema",
"requirement_type": "history",
"expected_value": true
}
]
},
{
"line": "* QTc interval over 450 msec or risk factors for torsades de pointes or on Class IA and Class III anti arrhythmic medications",
"criterions": [
{
"exact_snippets": [
"QTc interval over 450 msec"
],
"criterion": "QTc interval",
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 450
}
]
}
},
{
"exact_snippets": [
"risk factors for torsades de pointes"
],
"criterion": "torsades de pointes",
"requirement_type": "risk factors",
"expected_value": true
},
{
"exact_snippets": [
"on Class IA and Class III anti arrhythmic medications"
],
"criterion": "Class IA and Class III anti arrhythmic medications",
"requirement_type": "usage",
"expected_value": true
}
]
},
{
"line": "* Cancer within the last 5 years except prostate cancer and surgically removed basal or squamous cell carcinoma of the skin",
"criterions": [
{
"exact_snippets": [
"Cancer within the last 5 years"
],
"criterion": "cancer",
"requirement_type": "time since diagnosis",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5
}
]
}
},
{
"exact_snippets": [
"except prostate cancer"
],
"criterion": "prostate cancer",
"requirement_type": "exclusion",
"expected_value": true
},
{
"exact_snippets": [
"surgically removed basal or squamous cell carcinoma of the skin"
],
"criterion": "basal or squamous cell carcinoma of the skin",
"requirement_type": "surgical removal",
"expected_value": true
}
]
},
{
"line": "* Known or suspected hepatic, symptomatic biliary disease (this includes moderate to severe chronic hepatic impairment)",
"criterions": [
{
"exact_snippets": [
"Known or suspected hepatic"
],
"criterion": "hepatic disease",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"symptomatic biliary disease"
],
"criterion": "biliary disease",
"requirement_type": "symptomatic",
"expected_value": true
},
{
"exact_snippets": [
"moderate to severe chronic hepatic impairment"
],
"criterion": "chronic hepatic impairment",
"requirement_type": "severity",
"expected_value": [
"moderate",
"severe"
]
}
]
},
{
"line": "* Patients with clinically significant laboratory abnormalities / disorders other than prostate cancer",
"criterions": [
{
"exact_snippets": [
"clinically significant laboratory abnormalities"
],
"criterion": "laboratory abnormalities",
"requirement_type": "clinical significance",
"expected_value": true
},
{
"exact_snippets": [
"disorders other than prostate cancer"
],
"criterion": "disorders",
"requirement_type": "exclusion",
"expected_value": "prostate cancer"
}
]
},
{
"line": "* Patient with Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections",
"criterions": [
{
"exact_snippets": [
"Hepatitis B Virus (HBV)"
],
"criterion": "Hepatitis B Virus",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"Hepatitis C Virus (HCV)"
],
"criterion": "Hepatitis C Virus",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"Human Immunodeficiency Virus (HIV)"
],
"criterion": "Human Immunodeficiency Virus",
"requirement_type": "presence",
"expected_value": true
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}